Press Release Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means Read Press Release
Press Release Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release Read Press Release
Press Release Overwhelming Bipartisan Support for Access to FDA-Approved Alzheimer’s Treatments on Display in Health Subcommittee Hearing Read Press Release
